{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:47:34Z","timestamp":1766119654228,"version":"3.48.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jneuroim.2025.578809","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:36:40Z","timestamp":1763656600000},"page":"578809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early exposure of NOD\/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis"],"prefix":"10.1016","volume":"410","author":[{"given":"Giuseppe","family":"Ranieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Chiarugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Buonvicino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jneuroim.2025.578809_bb0005","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/db05-0810","article-title":"Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice","volume":"55","author":"Alard","year":"2006","journal-title":"Diabetes"},{"issue":"15","key":"10.1016\/j.jneuroim.2025.578809_bb0010","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s40265-018-0984-5","article-title":"Therapeutic advances and challenges in the treatment of progressive multiple sclerosis","volume":"78","author":"Baldassari","year":"2018","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578809_bb0015","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2337\/dc09-0373","article-title":"Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside","volume":"32","author":"Bresson","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jneuroim.2025.578809_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113065","article-title":"Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution","volume":"322","author":"Buonvicino","year":"2019","journal-title":"Exp. Neurol."},{"issue":"14","key":"10.1016\/j.jneuroim.2025.578809_bb0025","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/bph.15058","article-title":"Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis","volume":"177","author":"Buonvicino","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578809_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2021.04.002","article-title":"Treatment with non-specific HDAC inhibitors administered after disease onset does not delay evolution in a mouse model of progressive multiple sclerosis","volume":"465","author":"Buonvicino","year":"2021","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578809_bb0035","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12640-021-00331-3","article-title":"Cuprizone-dependent De\/remyelination responses and functional correlates in mouse strains adopted to model relapsing, chronic and progressive experimental autoimmune encephalomyelitis","volume":"39","author":"Buonvicino","year":"2021","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578809_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100855","article-title":"SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure","volume":"297","author":"Buonvicino","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2025.578809_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106015","article-title":"Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis","volume":"178","author":"Buonvicino","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578809_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106387","article-title":"The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis","volume":"191","author":"Buonvicino","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578809_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2015.06.019","article-title":"Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound","volume":"50","author":"Cavone","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578809_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1742-2094-8-73","article-title":"Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL\/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet","volume":"8","author":"Cravens","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578809_bb0065","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-3083.2010.02451.x","article-title":"Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents","volume":"72","author":"Donia","year":"2010","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578809_bb0070","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.4049\/jimmunol.1001596","article-title":"Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice","volume":"185","author":"Huszarik","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578809_bb0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4049\/jimmunol.172.2.937","article-title":"Regulation of autoimmune diabetes by complete Freund\u2019s adjuvant is mediated by NK cells","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578809_bb0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/eji.200737189","article-title":"Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes","volume":"38","author":"Lee","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578809_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ana.410170214","article-title":"Adoptive transfer of murine relapsing experimental allergic encephalomyelitis","volume":"17","author":"Lublin","year":"1985","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578809_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003739","article-title":"APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development","volume":"3","author":"Manirarora","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jneuroim.2025.578809_bb0095","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2741\/3866","article-title":"Structure and function of the thymic microenvironment","volume":"16","author":"Manley","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578809_bb0100","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4049\/jimmunol.1900662","article-title":"Regulatory T cell development in the Thymus","volume":"203","author":"Owen","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578809_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115095","article-title":"Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis","volume":"385","author":"Pistolesi","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578809_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177415","article-title":"The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis","volume":"995","author":"Pistolesi","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.jneuroim.2025.578809_bb0115","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/intimm\/dxh173","article-title":"In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma\/TNF-alpha","volume":"16","author":"Qin","year":"2004","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578809_bb0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diab.39.5.583","article-title":"Prevention of type I diabetes in NOD mice by adjuvant immunotherapy","volume":"39","author":"Sadelain","year":"1990","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578809_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2025.578809_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmmunity*","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578809_bb0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2005.08.002","article-title":"A comprehensive review of interventions in the NOD mouse and implications for translation","volume":"23","author":"Shoda","year":"2005","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578809_bb0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","article-title":"Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction","volume":"28","author":"Tang","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578809_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181933261","article-title":"Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy","volume":"87","author":"Tian","year":"2009","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578809_bb0150","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.89.9.3927","article-title":"A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund\u2019s adjuvant","volume":"89","author":"Ulaeto","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.jneuroim.2025.578809_bb0155","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1073\/pnas.172382999","article-title":"Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice","volume":"99","author":"Wu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T03:49:10Z","timestamp":1766116150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825002905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S0165572825002905"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578809","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early exposure of NOD\/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578809"}}